文献速递糖尿病性腺与生殖内分泌

绝经后激素治疗对1型或2型糖尿病女性血糖调节的影响:系统综述与Meta分析

Effect of Postmenopausal Hormone Therapy on Glucose Regulation in Women With Type 1 or Type 2 Diabetes: A Systematic Review and Meta-analysis.
PubMed 文献 · Diabetes Care · 2023-01-01

该系统综述与Meta分析纳入19项随机对照试验共1412名绝经后糖尿病女性,其中4.0%为1型糖尿病。激素治疗可降低糖化血红蛋白(平均差-0.56%[95%CI -0.80,-0.31])和空腹血糖(平均差-1.15 mmol/L[95%CI -1.78,-0.51])。作者认为,当2型糖尿病女性因更年期症状考虑绝经后激素治疗时,预期对血糖调节呈中性至有益影响,而1型糖尿病女性的证据有限。

要点

  • 激素治疗降低糖化血红蛋白平均差-0.56%(95%CI -0.80,-0.31),降低空腹血糖平均差-1.15 mmol/L(95%CI -1.78,-0.51)。
  • 纳入19项随机对照试验共1412名参与者,其中4.0%为1型糖尿病。
  • 2型糖尿病女性因更年期症状考虑激素治疗时,预期对血糖调节呈中性至有益影响。

核心结论

  • 当2型糖尿病女性因更年期症状考虑绝经后激素治疗时,激素治疗预期对血糖调节呈中性至有益影响。
  • 绝经后激素治疗对1型糖尿病女性影响的证据有限。

研究设计与样本

  • 系统检索MEDLINE、Embase、Scopus、Cochrane Library和ClinicalTrials.gov注册库以识别随机对照试验。
  • 纳入19项随机对照试验(12项平行组试验和7项交叉试验),共1412名参与者,其中4.0%为1型糖尿病。
  • 纳入标准为含雌激素治疗的激素治疗用于绝经后女性(末次月经后≥12个月)且患有1型或2型糖尿病的随机对照试验。

主要发现

  • 激素治疗降低糖化血红蛋白,平均差-0.56%(95%CI -0.80,-0.31),即-6.08 mmol/mol(95%CI -8.80,-3.36)。
  • 激素治疗降低空腹血糖,平均差-1.15 mmol/L(95%CI -1.78,-0.51)。

局限性

  • 纳入研究中50%存在高偏倚风险。
  • 绝经后激素治疗对1型糖尿病女性影响的证据有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Blood glucose regulation in women with diabetes may change during and after menopause, which could be attributed, in part, to decreased estrogen levels. PURPOSE: To determine the effect of postmenopausal hormone therapy (HT) on HbA1c, fasting glucose, postprandial glucose, and use of glucose-lowering drugs in women with type 1 and women with type 2 diabetes. DATA SOURCES: We conducted a systematic search of MEDLINE, Embase, Scopus, the Cochrane Library, and the ClinicalTrials.gov registry to identify randomized controlled trials (RCTs). STUDY SELECTION: We selected RCTs on the effect of HT containing estrogen therapy in postmenopausal women (≥12 months since final menstrual period) with type 1 or type 2 diabetes. DATA EXTRACTION: Data were extracted for the following outcomes: HbA1c, fasting glucose, postprandial glucose, and use of glucose-lowering medication. DATA SYNTHESIS: Nineteen RCTs were included (12 parallel-group trials and 7 crossover trials), with a total of 1,412 participants, of whom 4.0% had type 1 diabetes. HT reduced HbA1c (mean difference -0.56% [95% CI -0.80, -0.31], -6.08 mmol/mol [95% CI -8.80, -3.36]) and fasting glucose (mean difference -1.15 mmol/L [95% CI -1.78, -0.51]). LIMITATIONS: Of included studies, 50% were at high risk of bias. CONCLUSIONS: When postmenopausal HT is considered for menopausal symptoms in women with type 2 diabetes, HT is expected to have a neutral-to-beneficial impact on glucose regulation. Evidence for the effect of postmenopausal HT in women with type 1 diabetes was limited.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Speksnijder EM, Ten Noever de Brauw GV, Malekzadeh A, et al. Effect of Postmenopausal Hormone Therapy on Glucose Regulation in Women With Type 1 or Type 2 Diabetes: A Systematic Review and Meta-analysis. Diabetes Care. 2023. PMID: 37729504. doi:10.2337/dc23-0451

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。